Sandra A Acosta, Nick Franzese, Meaghan Staples, Nathan L Weinbren, Monica Babilonia, Jason Patel, Neil Merchant, Alejandra Jacotte Simancas, Adam Slakter, Mathew Caputo, Milan Patel, Giorgio Franyuti, Max H Franzblau, Lyanne Suarez, Chiara Gonzales-Portillo, Theo Diamandis, Kazutaka Shinozuka, Naoki Tajiri, Paul R Sanberg, Yuji Kaneko, Leslie W Miller, Cesar V Borlongan
Cell-based therapy is a promising therapy for myocardial infarction. Endogenous repair of the heart muscle after myocardial infarction is a challenge because adult cardiomyocytes have a limited capacity to proliferate and replace damaged cells. Pre-clinical and clinical evidence has shown that cell based therapy may promote revascularization and replacement of damaged myocytes after myocardial infarction. Adult stem cells can be harvested from different sources including bone marrow, skeletal myoblast, and human umbilical cord blood cells...
July 1, 2013: Journal of Stem Cell Research & Therapy